Compare AdaptHealth Corp (AHCO) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Vanguard Total International Stock Index Fund ETF — how do they compare? AdaptHealth Corp trades at $10.07 (market cap $1.38B), while Vanguard Total International Stock Index Fund ETF trades at $84.33. The key difference: Vanguard Total International Stock Index Fund ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | VXUS | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Sector/Thematic |
52-Week High | $13.38 | $87.06 |
52-Week Low | $8.68 | $68.24 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
VXUS trades at $86.17, up 1.57% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF provides diversified international equity exposure across developed and emerging markets, holding over 8,700 stocks. Recent news highlights its role in portfolio diversification amid high U.S. valuations, with Vanguard surpassing iShares as the largest ETF provider in June 2026.
VXUS offers a strategic hedge against U.S. market concentration, trading at a discount to domestic peers. Key risks include currency fluctuations, geopolitical tensions, and emerging market volatility. Analyst sentiment is positive due to broad diversification and cost efficiency, though performance depends on global economic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
